HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About HARBIN GLORIA PHARMACEUTICALS Co., LTD
—
HARBIN GLORIA PHARMACEUTICALS Co., LTD is led by CEO Leifeng Guo, employs 2,350 people, headquartered in Harbin, CN, publicly traded since 2011.
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) stock trades at $3.05 with a market capitalization of $8.99B. The stock is valued at a price-to-earnings (P/E) ratio of 22.39, price-to-book of 3.92, price-to-sales of 4.23. Over the past 52 weeks the stock has ranged between $2.37 and $5.10, and currently trades 40.2% below its 52-week high.
On profitability, HARBIN GLORIA PHARMACEUTICALS Co., LTD generates a return on equity (ROE) of 19.11%, above the typical market range of roughly 12-15%, an operating margin of 14.09%, a net profit margin of 19.38%.
Official website: www.gloria.cc
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) — frequently asked questions
What is HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) stock price today?
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) is currently trading at $3.05, down 6.44% today.
What is 002437.SZ P/E ratio?
HARBIN GLORIA PHARMACEUTICALS Co., LTD's P/E ratio is 22.39. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 002437.SZ return on equity (ROE)?
HARBIN GLORIA PHARMACEUTICALS Co., LTD's return on equity (ROE) is 19.11%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is HARBIN GLORIA PHARMACEUTICALS Co., LTD's market cap?
HARBIN GLORIA PHARMACEUTICALS Co., LTD has a market capitalization of $8.99B.
Does 002437.SZ pay a dividend?
HARBIN GLORIA PHARMACEUTICALS Co., LTD is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 002437.SZ carry?
HARBIN GLORIA PHARMACEUTICALS Co., LTD has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002437.SZ's profit margin?
HARBIN GLORIA PHARMACEUTICALS Co., LTD reports a net profit margin of 19.38% — the share of revenue left after every cost, including tax and interest.
What sector is 002437.SZ in?
HARBIN GLORIA PHARMACEUTICALS Co., LTD is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002437.SZ listed on?
HARBIN GLORIA PHARMACEUTICALS Co., LTD trades on SHZ under the ticker 002437.SZ.
What is 002437.SZ's 52-week range?
Over the last year HARBIN GLORIA PHARMACEUTICALS Co., LTD has traded between $2.37 and $5.10.
Related — Stocks
Popular Stocks
Screens 002437.SZ currently matches
On the figures above, HARBIN GLORIA PHARMACEUTICALS Co., LTD passes the filters for 14 of our ready-made screens, among them Low Debt Stocks, Day Losers Stocks, Penny Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.